The Trump administration is considering restricting access to mifepristone, a medication used in nearly two-thirds of abortions in the United States and widely prescribed for miscarriage management. pproved by the Food and Drug Administration (FDA) 25 years ago, mifepristone has consistently been shown to be safe and effective. Although the FDA originally imposed burdensome Risk Evaluation and Mitigation Strategy (REMS) restrictions on the medication, it eased these requirements over time in response to extensive research supporting the drug’s safety.